4//SEC Filing
Epizyme, Inc. 4
Accession 0001209191-14-009945
CIK 0001571498operating
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 7:57 PM ET
Size
8.8 KB
Accession
0001209191-14-009945
Insider Transaction Report
Form 4
Epizyme, Inc.EPZM
Hedrick Eric
Chief Medical Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2014-02-10−13,500→ 286,500 totalExercise: $2.19Exp: 2022-06-06→ Common Stock (13,500 underlying) - Exercise/Conversion
Common Stock, par value $0.0001 per share
2014-02-10$2.19/sh+13,500$29,565→ 13,500 total - Sale
Common Stock, par value $0.0001 per share
2014-02-10$29.25/sh−13,500$394,875→ 0 total
Footnotes (2)
- [F1]The sale transaction reported on this Form 4 was effected as a part of an underwritten public offering of common stock by Epizyme, Inc. with the Reporting Person as a selling stockholder in the offering.
- [F2]This option was granted on June 7, 2012 with respect to 300,000 shares of Common Stock, with 25% vesting on May 8, 2013 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Epizyme, Inc.
CIK 0001571498
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001571498
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 7:57 PM ET
- Size
- 8.8 KB